November 2026 · Issue 03

Diabetes, Earlier.

Are we protecting organs soon enough?

The newest evidence, a changing treatment philosophy, and the realities of Philippine practice.

View Magazine Download PDF Publication archive

Highlights from this issue

Cover Feature7 min read

Diabetes, Earlier.

Are we protecting organs soon enough? New international evidence. Philippine clinical realities. Decisions that matter from diagnosis.

Read article

Evidence Synthesis5 min read

Septic Shock: Have We Been Giving Too Much Fluid?

Early vasopressors, fluid volumes, and the evidence behind better resuscitation decisions.

Read article

Therapeutic Review4 min read

COPD Beyond Inhalers

Can biologics reach more patients? IL-33 inhibition may extend exacerbation prevention beyond eosinophil-selected trials, but important questions remain.

Read article

Digital edition

Inside Issue 03

10 articles

Editorial2 min read

From Evidence to Better Decisions

New evidence deserves attention. Better care requires interpretation, clinical judgment, and an understanding of the healthcare setting.

Read article

Evidence Update2 min read

Papers Worth Knowing

Four studies. Four clinically important questions.

Read article

Cover Feature7 min read

Diabetes, Earlier.

Are we protecting organs soon enough? New international evidence. Philippine clinical realities. Decisions that matter from diagnosis.

Read article

Evidence Synthesis5 min read

Septic Shock: Have We Been Giving Too Much Fluid?

Early vasopressors, fluid volumes, and the evidence behind better resuscitation decisions.

Read article

Therapeutic Review4 min read

COPD Beyond Inhalers

Can biologics reach more patients? IL-33 inhibition may extend exacerbation prevention beyond eosinophil-selected trials, but important questions remain.

Read article